Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02485158Completed
Randomised, double-blind trial of dextroamphetamine, ethanol and dronabinol, sponsored by University of Chicago. Primary endpoints: Change in General Drug Effects (Drug Effects Questionnaire) at 210 months and Change in Specific Drug Effects (Addiction Research Center Inventory) at 210 months. Started Jul 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02485158.